Cancer Drug Fund: the story so far

See how the Cancer Drug Fund has been spent across England since it was introduced in 2010

DH: Cancer Drug Fund launched in October 2010
DH: Cancer Drug Fund launched in October 2010

The Cancer Drug Fund was introduced by the Coalition government in October 2010 to provide funding for cancer drugs that NICE does not approve as a cost-effective use of NHS resources.

Ministers rejected claims that the fund would undermine NICE’s role in appraising the cost effectiveness of drugs.

Since then, the fund has provided treatment for over 18,000 patients.

In late August, the DH released the latest figures on how the fund had been used across the country. These cover the period from October 2010 to June 2012.

Then care services minister Paul Burstow said: 'Cancer patients, no matter where they live should have access to the drugs their doctors recommend, which is why we introduced the Cancer Drugs Fund. By publishing this data, patients can see how the fund is being used in their area and across the country.'

The figures show some parts of the country have received almost four times as much of the funds per head of the population as other regions.

Funding for 2012/13 is allocated to SHAs using the national weighted capitation formula, which takes account of factors such as population demographics and additional need.


CDF title=

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

No plans to impose face-to-face GP appointment targets, Hancock tells BMA

No plans to impose face-to-face GP appointment targets, Hancock tells BMA

The government has no plans to impose face-to-face appointments targets on general...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

COVID-19 variants could force UK to revaccinate over next 2-3 years warns CMO

COVID-19 variants could force UK to revaccinate over next 2-3 years warns CMO

The UK's chief medical adviser has warned that new coronavirus variants may force...

BMA condemns 'fundamentally flawed' £20m weight management enhanced service

BMA condemns 'fundamentally flawed' £20m weight management enhanced service

The BMA has condemned a £20m weight management enhanced service as 'fundamentally...

GP contract update delivers extra PCN cash and £50m for new enhanced services

GP contract update delivers extra PCN cash and £50m for new enhanced services

An update to the GP contract agreement for 2021/22 has set out details of enhanced...

CQC rejects call for independent review to look at BAME bias in ratings

CQC rejects call for independent review to look at BAME bias in ratings

The CQC has rejected calls for an independent review of its ratings process to look...